key: cord-1000063-c5bv16c4
authors: Verma, Rohit; Saha, Sandhini; Kumar, Shiv; Mani, Shailendra; Maiti, Tushar Kanti; Surjit, Milan
title: RNA-Protein Interaction Analysis of SARS-CoV-2 5′ and 3′ Untranslated Regions Reveals a Role of Lysosome-Associated Membrane Protein-2a during Viral Infection
date: 2021-07-13
journal: mSystems
DOI: 10.1128/msystems.00643-21
sha: b52ebe17b8dd40ba55448df6723320b2e18ce563
doc_id: 1000063
cord_uid: c5bv16c4

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a positive-strand RNA virus. The viral genome is capped at the 5′ end, followed by an untranslated region (UTR). There is a poly(A) tail at the 3′ end, preceded by a UTR. The self-interaction between the RNA regulatory elements present within the 5′ and 3′ UTRs and their interaction with host/virus-encoded proteins mediate the function of the 5′ and 3′ UTRs. Using an RNA-protein interaction detection (RaPID) assay coupled to liquid chromatography with tandem mass spectrometry, we identified host interaction partners of SARS-CoV-2 5′ and 3′ UTRs and generated an RNA-protein interaction network. By combining these data with the previously known protein-protein interaction data proposed to be involved in virus replication, we generated the RNA-protein-protein interaction (RPPI) network, likely to be essential for controlling SARS-CoV-2 replication. Notably, bioinformatics analysis of the RPPI network revealed the enrichment of factors involved in translation initiation and RNA metabolism. Lysosome-associated membrane protein-2a (Lamp2a), the receptor for chaperone-mediated autophagy, is one of the host proteins that interact with the 5′ UTR. Further studies showed that the Lamp2 level is upregulated in SARS-CoV-2-infected cells and that the absence of the Lamp2a isoform enhanced the viral RNA level whereas its overexpression significantly reduced the viral RNA level. Lamp2a and viral RNA colocalize in the infected cells, and there is an increased autophagic flux in infected cells, although there is no change in the formation of autophagolysosomes. In summary, our study provides a useful resource of SARS-CoV-2 5′ and 3′ UTR binding proteins and reveals the role of Lamp2a protein during SARS-CoV-2 infection. IMPORTANCE Replication of a positive-strand RNA virus involves an RNA-protein complex consisting of viral genomic RNA, host RNA(s), virus-encoded proteins, and host proteins. Dissecting out individual components of the replication complex will help decode the mechanism of viral replication. 5′ and 3′ UTRs in positive-strand RNA viruses play essential regulatory roles in virus replication. Here, we identified the host proteins that associate with the UTRs of SARS-CoV-2, combined those data with the previously known protein-protein interaction data (expected to be involved in virus replication), and generated the RNA-protein-protein interaction (RPPI) network. Analysis of the RPPI network revealed the enrichment of factors involved in translation initiation and RNA metabolism, which are important for virus replication. Analysis of one of the interaction partners of the 5′-UTR (Lamp2a) demonstrated its role in reducing the viral RNA level in SARS-CoV-2-infected cells. Collectively, our study provides a resource of SARS-CoV-2 UTR-binding proteins and identifies an important role for host Lamp2a protein during viral infection.

IMPORTANCE Replication of a positive-strand RNA virus involves an RNA-protein complex consisting of viral genomic RNA, host RNA(s), virus-encoded proteins, and host proteins. Dissecting out individual components of the replication complex will help decode the mechanism of viral replication. 59 and 39 UTRs in positive-strand RNA viruses play essential regulatory roles in virus replication. Here, we identified the host proteins that associate with the UTRs of SARS-CoV-2, combined those data with the previously known protein-protein interaction data (expected to be involved in virus replication), and generated the RNA-protein-protein interaction (RPPI) network. Analysis of the RPPI network revealed the enrichment of factors involved in translation initiation and RNA metabolism, which are important for virus replication. Analysis of one of the interaction partners of the 59-UTR (Lamp2a) demonstrated its role in reducing the viral RNA level in SARS-CoV-2-infected cells. Collectively, our study provides a resource of SARS-CoV-2 UTR-binding proteins and identifies an important role for host Lamp2a protein during viral infection.

activator p100 (SND1), and heat shock proteins (HSP40, HSP60, HSP70) associate with the 39 UTR of MHV (19) . The functional significance of some of these interactions is known (8) .

Despite general acceptance of the importance of the 59 and 39 UTRs of RNA viruses in controlling their replication and pathogenesis, no systematic study has been undertaken to elucidate the molecular composition of the RNA-protein complex assembled at the 59 and 39 UTRs of SARS-CoV-2 and the function of 59 and 39 UTRs of SARS-CoV-2.

We employed an RNA-protein interaction detection (RaPID) assay coupled to liquid chromatography with tandem mass spectrometry (LC-MS/MS) to identify the repertoire of host proteins that interact with the SARS-CoV-2 59 and 39 UTRs (20) . These data sets were used to construct the virus-host RNA-protein-protein interaction (RPPI) network. In silico analyses of the RPPI network revealed enrichment of proteins involved in multiple processes, such as Cap-dependent translation and RNA metabolism. Further studies revealed an antiviral role of LAMP2a during SARS-CoV-2 infection. The functional significance of these findings in SARS-CoV-2 replication and pathogenesis is discussed.

Identification of host proteins that interact with the 59 and 39 UTRs of SARS-CoV-2 genomic RNA. Three hundred nucleotides from the 59 end (designated the 59-UTR RNA) and 203 nucleotides from the 39 end (39-UTR RNA) of the SARS-CoV-2 genomic RNA (Wuhan isolate), which includes the 59 and 39 UTRs (nucleotides 1 to 265 and 29676 to 29878, respectively, in the viral genome), were cloned into the pRMB vector between the BirA ligase binding stem-loop (SL-A and SL-B) sequences ( Fig. 1A to C). 59 and 39 UTRs consist of 265 and 228 nucleotides, respectively. Extra bases were included at the 59 end to ensure that stem-loops in the predicted secondary structures of the 59 UTR remain intact in the hybrid RNA (Fig. 1A) . Eight adenine residues were retained at the 39 end (Fig. 1B ). An mfold-mediated comparison of the secondary structures of the 59 300-nucleotide and 39 203-nucleotide RNA sequences with and without BirA ligase binding stem-loop RNA sequences indicated that secondary structures of viral 59 UTR and 39 UTR and BirA binding stem-loops (SL-A and SL-B) are not disturbed in the hybrid RNA sequence ( Fig. 1A and B ; see Fig. S1 and S2 in the supplemental material). A RaPID (RNA-protein interaction detection) assay was performed to identify the host proteins that interact with the 59-UTR and 39-UTR RNA in HEK293T cells. The RaPID assay allows BirA ligase-mediated in vivo biotin labeling of host proteins that interact with the RNA sequence of interest cloned between the BirA ligase-binding RNA motifs. Biotinylated proteins are captured using streptavidin agarose beads and identified by LC-MS/MS (Fig. 1C) (20) . Thus, both transiently interacting and stably interacting proteins can be identified using this technique.

Expression of BirA ligase in HEK293T cells was confirmed by Western blotting using anti-hemagglutinin (anti-HA) antibody that recognizes the HA tag fused to the BirA ligase (Fig. 1D) . The optimal duration of biotin treatment was selected through a time course analysis of biotin labeling, based on which an 18-h labeling period was selected (Fig. 1E) . To test the functionality of the RaPID assay, a known RNA-protein interaction was tested. We measured the interaction between a UG-rich RNA sequence called EDEN15 and CUGBP1 protein (CUG triplet repeat, RNA binding protein 1) by the RaPID assay as a positive control because an earlier study demonstrated their interaction by RaPID assay (20) . Streptavidin pulldown of EDEN15 RNA-interacting proteins, followed by Western blotting using CUGBP1 antibody, revealed the interaction between them, in agreement with an earlier report and confirming the validity of the technique under our laboratory condition (Fig. 1F) (20) .

HEK293T cells expressing the SL-A-59 UTR-SL-B or SL-A-39 UTR-SL-B or SL-A-SL-B (pRMB) were treated with biotin, followed by pulldown of biotinylated proteins and LC-MS/MS analysis. Biotin-untreated cells were processed in parallel as a control. Samples from three independent experiments were run in triplicate. Pearson correlation analysis of MS data demonstrated good correlation between replicates for individual biological samples (average range, 0.5 to 0.98) ( Fig. 2A) . Specific and strong interaction partners of 59-UTR and 39-UTR RNAs were identified in three steps: (i) only those proteins having at least one biotinylated peptide and a posterior error probability (PEP) score of 15 or more in all LC-MS samples were selected ( Fig. S3 ; Table S1) (21) ; (ii) proteins were selected after subtraction of pRMB data set from 59-UTR and 39-UTR data sets (Fig. 2B) ; (iii) from the background-subtracted data set, only those proteins with a minimum of two unique peptides and a "prot score" of 40 or more were considered for further analysis (Table 1 ) (see Materials and Methods).

By using a similar protocol, in an unrelated study, we had identified host interaction partners of the 39 end (39 UTR plus adjacent 100 nucleotides) of hepatitis E virus (HEV) genomic RNA (Table S2) . HEV is a positive-strand RNA virus of the Hepeviridae family, and the 39 end of HEV harbors a secondary structure composed of multiple stem-loops that have been predicted to be important for viral replication (22) . In order to further increase our confidence in the reliability of the RaPID technique, the HEV 39-end RNAinteracting protein list was compared to the SARS-CoV-2 59-UTR and 39-UTR RNA-interacting protein list. One protein (histone H3.1) was found to be in common for the two data sets, indicating specificity of the interacting proteins for the RNA baits. Therefore, using the RaPID assay, 47 and 14 host proteins were identified to interact with the 59-UTR RNA and 39-UTR RNA, respectively ( Table 1) . Out of these, 4 proteins (UBA1, GNL2, JAKMIP3, and YTHDF3) interacted with both 59 and 39 UTRs (Table 1 , represented in bold font). A search in the Human Protein Atlas data bank revealed that 55 of 57 host proteins identified in the RaPID assay are expressed in both lungs and intestine of human (Table S3) .

Recently, two independent studies identified the RNA-protein interactome of the SARS-CoV-2 genome by use of the RAP-MS (RNA antisense purification with mass spectrometry) and ChIRP-MS (comprehensive identification of RNA-binding proteins by mass spectrometry) techniques (23, 24) . A comparison with those data identified 27 proteins to be common to the three data sets (Table 2) . Of those proteins, 11 are common between RaPID and RAP-MS data and 25 proteins are common between RaPID and ChIRP-MS data ( Table 2 ). The majority of common proteins are bound to the 59 UTR (23 proteins).

Recent studies have also identified a number of host factors that are important for SARS-CoV-2 infection (24) (25) (26) . In order to gain a functional insight into the RaPID-identified host protein data set, we next searched for host proteins that are common between the RaPID data and the CRISPR knockout screening data. Six SARS-CoV-2 59-UTR RNA-binding host proteins were found to be present in the CRISPR knockout screening data set reported by Daniloski et al. (25) . One of the 59-UTR binding proteins (TPR) identified to be important for SARS-CoV-2 infection in the study of Daniloski et al. was also found to be present in the CRISPR knockout screening data set reported by Wei et al. (26) . Nine proteins were found to be present in the CRISPR knockout screening data set reported by Flynn et al. (25) , of which 7 proteins were bound to the 59-UTR RNA and 2 proteins were bound to the 39-UTR RNA ( Table 2 ). Of the 9 proteins, only G3BP2 displayed proviral characteristics, whereas the remaining 8 proteins showed antiviral characteristics. Collectively, these analyses support an important role of the RaPID-identified host proteins in the SARS-CoV-2 infection process.

Construction and analysis of the RPPI network at the 59 and 39 ends of the SARS-CoV-2 genome. 59-UTR and 39-UTR RNA binding protein data sets were imported to Cytoscape to construct the RNA-protein-protein interaction (RPPI) network (27) . Analysis of the network parameters such as edge (number of interactions), node (protein), node degree (number of interactions linked to a protein), and clustering coefficient (tendency of nodes to remain in a cluster) revealed that 39-UTR interacting proteins did not show any significant network characteristics (Fig. S3B ). Note that a PPI network is considered significant when the observed network connectivity is Fig. S3C ). Next, gene ontology (GO) and Reactome pathway analysis of the RPPI network was performed using the Gene Set Enrichment Analysis (GSEA) tool to determine the significantly enriched processes/pathways ( Fig. S4 and S5) (28, 29) . Of note, proteins involved in intracellular transport, translation initiation, amide biosynthetic pathway, and mRNA metabolism were enriched in the GO-biological processes category (Table 3) . Similarly, proteins involved in cellular response to external stimuli, HSP90 chaperones for steroid hormone receptors, RNA metabolism, translation, influenza virus infection, infectious disease, and cell cycle, etc., were enriched in Reactome pathway analysis (Table 3 ). Since 59 and 39 UTRs are well conserved, drugs directly targeting the UTRs or acting upon the proteins that interact with the UTRs may function as potent antivirals by inhibiting the viral replication process.

Analysis of the 57 proteins identified in RaPID assay using the CyTarget Linker plugin in Cytoscape software (30) as well as the Drug Gene Interaction Database (DGID) (31) identified 5 proteins against which known drugs exist. Of these 5 proteins, HABP4, TUB1A1, and PLA2G4A are reported to be targeted by hyaluronan, albendazole, and fluticasone propionate, respectively (32) (33) (34) (35) . NADH and tetrahydrofolic acid are cofactors for PDHA1 and MTHFD1, respectively (35) ( Table 4) .

Lamp2 is a host restriction factor against SARS-CoV-2. Lamp2a (CD107b) was identified as an interaction partner of the 59-UTR RNA in the RaPID assay. LAMp2a is the receptor for chaperone-mediated autophagy (CMA), and recent studies have The level of viral RNA in the culture medium (from released virus) and inside the cells (intracellular) was then measured by quantitative real-time PCR (RT-qPCR) analysis of 48-h and 72-h SARS-CoV-2-infected samples by using a SYBR green-based method. RT-qPCR detection of RNA polymerase II (RP II) and RNase P (RP) served as a normalization control for intracellular and secreted RNA quantities, respectively. An increase in viral RNA level was observed in 72-h infected intracellular and secreted samples, compared to 48-h infected samples, indicating productive infection of Vero E6 cells with SARS-CoV-2 ( Fig. 3C) . Aliquots of the RNA from culture medium were also used in a TaqMan probebased one-step RT-qPCR analysis using primers and probes recommended by the Centers for Disease Control and Prevention (CDC), USA, for detection of SARS-CoV-2 ( Fig. 3D ). SYBR green and TaqMan RT-qPCR methods showed comparable results, and hence, the SYBR green method was used in subsequent experiments. Collectively, these data demonstrate the establishment of the Vero E6 infection model of SARS-CoV-2 in our experimental setups.

Fluorescence in situ hybridization (FISH) was conducted to monitor the interaction between the 59-UTRs of the viral genome and Lamp2 in SARS-CoV-2-infected Vero E6 cells. Lamp2 (green)-and 59-UTR RNA-specific (red) probes colocalized (indicated by yellow), suggesting their interaction (Fig. 4A ). Next, SMARTpool small interfering RNA (siRNA) targeting Lamp2 RNA (targets all Lamp2 isoforms, pan-Lamp2 siRNA, designated Lamp2 siRNA) was used to deplete Lamp2 protein in Vero E6 cells. Western blotting of Vero E6 whole-cell extract after 48 and 72 h of Lamp2 siRNA transfection demonstrated that siRNA was effective in reducing the total Lamp2 level by .90% in siRNA-transfected cells (Fig. 4B , upper panel). GAPDH was used as a loading control (Fig. 4B , lower panel). RT-qPCR of 72-h siRNA-transfected SARS-CoV-2-infected Vero E6 cells (analyzed 48 h postinfection) revealed an increase in viral RNA level both in the culture medium (Fig. 4C ) and inside the cells (Fig. 4D) . Western blot analysis of an aliquot of the whole-cell extracts using anti-N antibody showed increased nucleocapsid protein level in Lamp2 siRNA-treated SARS-CoV-2-infected cells, compared to that in nontargeting (NT) siRNA-treated SARS-CoV-2-infected cells (Fig. 4E, upper panel) . Western blotting of the GAPDH protein level served as a loading control (Fig. 4E, Tetrahydrofolic acid (35) 39-UTR RNA-interacting host proteins TUBA1A Albendazole (32) PLA2G4A

Fluticasone propionate (34) Huh7 cells as a viable model for SARS-CoV-2 infection (23, 37) . We observed the same effect in a Huh7 cell-based infection model of SARS-CoV-2 ( Fig. S6A to S6F ). Lamp2 is present in three different forms in mammalian cells, including Lamp2a, Lamp2b, and Lamp2c, produced through alternative splicing (38) . Lamp2a and Lamp2b are the major forms. Lamp2a is highly expressed in lungs, liver, and placenta. Lamp2b varies from Lamp2a in the last 11 amino acids of its C-terminal sequence, and it is highly expressed in skeletal muscle (39) . Lamp2 antibody used in this study recognizes all three Lamp2 variants.

Next, we tested if a particular Lamp2 isoform is responsible for increased viral replication in Lamp2 siRNA-treated cells by designing siRNA against each isoform of Lamp2. Analysis of Lamp2 sequence in multiple siRNA designing platforms indicated that specific siRNAs could be designed only against the Lamp2a and Lamp2b isoforms. siRNAs against human Lamp2a and Lamp2b were synthesized (details provided in Materials and Methods), and their silencing efficacy was tested in Huh7 cells. Western blot analysis of Lamp2a, Lamp2b, and pan-Lamp2 siRNA-treated Huh7 cell whole-cell extract revealed that both Lamp2a and pan-Lamp2 siRNAs significantly reduced the total Lamp2 protein level at both 48 and 72 h of treatment. Lamp2b siRNA treatment reduced the total Lamp2 protein level to a much lesser extent (Fig. 4F) . In order to confirm the specificity of the Lamp2a and Lamp2b siRNAs, an RT-qPCR was performed in 72-h siRNA-treated samples using primers specific to both isoforms. As expected, isoform-specific siRNAs specifically reduced the level of corresponding RNA whereas pan-Lamp2 siRNA (designated Lamp2 siRNA) effectively reduced the level of both Lamp2a and Lamp2b isoforms (Fig. 4G) . It was also clear that both Lamp2a and Lamp2b siRNAs were effective in reducing the Lamp2a and Lamp2b RNA levels by .80% (Fig. 4G ) and that Lamp2a is the dominant isoform in Huh7 cells. Next, Huh7 cells were treated with Lamp2a and Lamp2b siRNAs, followed by infection with SARS-CoV-2 and measurement of viral replication by RT-qPCR. Only Lamp2a siRNA-treated samples showed an increased level of viral RNA both in the culture medium and at the intracellular level ( Fig. 4H and I). Western blot analysis of a whole-cell extract of aliquots of the same sample showed an increase in the viral N protein level in Lamp2a siRNA-treated cells (Fig. 4J) .

Next, the effect of overexpression of each Lamp2 isoform on SARS-CoV-2 replication was tested. Overexpression of Lamp2a and Lamp2b significantly reduced the viral RNA level, whereas Lamp2c overexpression did not alter viral the RNA level at 48 h postinfection, both in culture medium (Fig. 5A ) and in intracellular samples in Vero E6 cells (Fig. 5B) . Lamp2a, Lamp2b, and Lamp2c overexpression was confirmed in aliquots of the sample using anti-lamp2 antibody, which recognizes all Lamp2 variants (Fig. 5C to E), and using anti-HA antibody (for Lamp2a). Similar results were obtained in the Huh7 cell-based model of SARS-CoV-2 infection (Fig. S6G to S6K ). Note that overexpressed Lamp2a and Lamp2b could be detected using both anti-HA and anti-Lamp2 antibodies in Huh7 cells but overexpressed Lamp2b could be detected using only anti-Lamp2 antibody in Vero E6 cells. Also note that no epitope tag is present in the Lamp2c expression clone. Hence, it was detected using anti-Lamp2 antibody.

In order to test if the observed reduction in viral RNA levels were specific to Lamp2, the effect of Lamp1 depletion on SARS-CoV-2 replication was evaluated. Western blot analysis using anti-Lamp1 antibody showed ;90% reduction in Lamp1 protein level in siRNA-transfected Huh7 cells at 48-h and 72-h time points (Fig. 5F ). RT-qPCR analysis of Lamp1 siRNA-treated SARS-CoV-2-infected cells did not show any significant change in the level of viral RNA in culture medium (Fig. 5G ) and intracellular samples (Fig. 5H) .

Increased Lamp2 protein level in SARS-CoV-2-infected cells does not promote chaperone-mediated autophagy or autophagolysosome formation. Lamp2a is the receptor for chaperone-mediated autophagy (CMA), and silencing of Lamp2 expression promoted SARS-CoV-2 replication. GAPDH is known to be degraded by CMA, and a reduced GAPDH level is considered to be an indicator of CMA activation in a cell. An increase in the level of LAMP2 was observed; however, no significant change in GAPDH level was observed in SARS-CoV-2-infected Vero E6 or Huh7 cells, suggesting that CMA is not activated in these cells (Fig. 6A) . We next measured the status of macroautophagy in SARS-CoV-2-infected cells. An increase in the level of LC3 II and p62 protein was observed in SARS-CoV-2-infected Vero E6 and Huh7 cells (Fig. 6A ). No change in the level of Lamp1 was observed (Fig. 6A) . Treatment of SARS-CoV-2infected Vero E6 and Huh7 cells with 3-methyladenine (3-MA), which is a specific inhibitor of autophagy, completely diminished viral RNA in both culture medium and intracellular samples (Fig. 6B to G) . Cell viability measurement of aliquots of the same samples ensured that 3-MA treatment did not cause cytotoxicity (Fig. 6B and E) . Immunofluorescence staining of Lamp2 (green) and LC3 (red) proteins was then performed in SARS-CoV-2-infected or uninfected Vero E6 cells. Formation of autophagolysosome is indicated by colocalization of Lamp2 and LC3, which forms yellow colored puncta in dual-stained cells (40) . No increase in autophagolysosome formation was visible in SARS-CoV-2-infected Vero E6 cells (Fig. 6H ).

In this study, we identified 57 host proteins that interact with the 59 and 39 UTRs of the SARS-CoV-2 genomic RNA, combined those data sets with the PPI data set proposed to be involved in viral replication, and constructed an RPPI network, which is likely to be assembled during the replication of SARS-CoV-2. Interactions of 59 and 39 regulatory elements with virus-encoded and host proteins mediate their function. Since 59 and 39 regulatory elements are known to play indispensable roles in the replication process of RNA viruses, identification of the components of the above-mentioned RNA-protein complex paves the way for designing novel antiviral therapeutic strategies against SARS-CoV-2.

During the course of this study, Schmidt et al. and Flynn et al. identified a number of host proteins that bind to SARS-CoV-2 RNA in infected Huh7 cells using the RAP-MS and ChIRP-MS techniques, respectively (23, 24) . In contrast, our study focused on the identification of host proteins that directly or indirectly associate with the 59 and 39 UTRs of SARS-CoV-2. The RaPID assay was used to capture the RNA-binding host proteins. The RaPID assay relies on in vivo biotinylation of proteins that bind to the RNA of interest, which is expressed as a chimeric RNA in fusion with BirA ligase-recognizing RNA motifs. Under conditions of biotin availability, the BirA ligase biotinylates all proteins in its close proximity (;10-nm range), including those associated with the RNA of interest. Thus, the RaPID assay detects both transient and stable interaction partners of an RNA under normal culture conditions. Since the RaPID protocol allows stringent washing of the pulldown samples, nonspecific binders are easily removed during the assay. Nonspecific proteins were further removed from the mass spectrometry data by using the following three controls: (i) subtraction of 59-and 39-UTR binding protein data sets from that of pRMB vector (which expresses the BirA-recognizing RNA motif), (ii) subtraction of 59-and 39-UTR binding protein data sets from that of pRMB HEV 39 UTR (an unrelated RNA sequence derived from the 39 UTR of HEV), and (iii) subtraction of 59-and 39-UTR binding protein data sets from that of a "no biotin treatment" control. However, it is noteworthy that the RaPID assay protocol used by us biotinylates the lysines exposed on the surface of proteins within close proximity and thus it has the inherent limitation that not all RNA binding proteins may be equally detected. Also, the specificity of the data may be further enhanced by using an additional control, which includes parallel processing of cells expressing pRMB 59and 39-UTR RNAs in the absence of BirA ligase expression. Nevertheless, comparison of our RaPID data set with the data obtained by two other RNA-protein interaction detection techniques (RAP-MS and ChIRP-MS) identified 27 common proteins. Almost 50% overlap of our data set with those from other independent studies supports the specificity of our assay. Our study identified an additional 30 host proteins that associate with 59 and 39 UTRs of SARS-CoV-2 RNA. This may be attributed to the ability of the RaPID technique to detect both stable and transient as well as direct and indirect (as a protein complex) RNA-protein interactions. The specificity of the data is evident from the fact that only one protein (HIST1H3) is common between SARS-CoV-2 and HEV RPPI data sets. Note that like SARS-CoV-2, HEV is also a positive-strand RNA virus which contains a capped 59 end, followed by a 59 UTR and poly(A) tail preceded by a 39 UTR (41) . Therefore, some aspects of the replication process might be similar in the two viruses.

In addition to infecting lungs, SARS-CoV-2 has been reported to cause enteric infections. A high level of ACE2 is expressed in the intestinal epithelial cells, and COVID-19 patients suffer from gastrointestinal disorders (4) . Therefore, we hypothesized that host proteins that are crucial for the survival of the virus are expressed in both lung and intestinal epithelium cells. A comparison of expression of 59-UTR and 39-UTR RNA binding proteins in lung and intestinal epithelium cells showed that 55 out of 57 proteins are expressed in both tissues, in support of the above statement.

Among the 59-and 39-UTR-interacting host proteins, HABP4, TUBA1A, and PLA2G4A are known to be targeted by hyaluronan, albendazole, and fluticasone propionate, respectively. Additionally, NADH and tetrahydrofolic acid act as cofactors for PDHA1 and MTHFD1, respectively. Further studies are required to demonstrate if these drugs play a role during SARS-CoV-2 infection.

Recently, a protein interaction map of SARS-CoV-2 has been reported (42) . Since the RNA-protein complex assembled at the 59 and 39 UTRs and the viral RNA-dependent RNA polymerase (RdRp)-associated protein complex are known to drive the viral replication process in positive-strand RNA viruses, we combined the 59-UTR 1 39-UTR RPPI data set and a previously reported PPI data set (only the subset of PPI proposed by Gordon and coworkers to be involved in viral replication) to generate an integrated RPPI network of SARS-CoV-2 replication machinery (see Fig. S7 in the supplemental material). As expected, the integrated RPPI network showed significantly higher PPI enrichment than the replication PPI alone, suggesting that in infected cells, there is close proximity between the 59 and 39 ends of the viral RNA and assembly of an RNAprotein complex consisting of viral 59 UTR, 39 UTR, virus-encoded proteins, and host proteins ( Fig. S7A and B) . PPIs among the 59-and 39-UTR RNA-interacting proteins likely bridge the 59 and 39 ends of the genome.

Gene ontology and Reactome pathway analysis of the SARS-CoV-2 59-and 39-UTR RPPI data sets show an enrichment of proteins involved in different processes, such as translation initiation, RNA metabolism, and infectious disease, which is expected. Therefore, the data obtained by the RaPID assay is a useful resource for future studies related to SARS-CoV-2. A comparison of SARS-CoV-2 59-UTR and 39-UTR-interacting proteins obtained in the RaPID assay with those shown in other positive-strand RNA viruses reveal a similar profile of many functional protein categories. Proteins belonging to the ribosome complex such as RPL7a, RPLP2, RPL13, and RPL4 and translation initiation factors such as eIF5B were found to interact with the SARS-CoV-2 59 and 39 UTR. Being a capped RNA, SARS-CoV-2 genomic RNA is supposed to utilize the canonical cap-dependent translation process for producing viral proteins, and the aboveidentified host factors might be used by the virus for efficiently translating its own RNA. The importance of host ribosomal proteins and translation regulators in the SARS-CoV-2 life cycle is supported by the finding that knockout of RPL7a, RPL13, and eIF5B significantly affected virus growth (25, 26) . Heat shock proteins of the HSP70 and HSP90 family are required for maintenance of cellular homeostasis by virtue of their ability to recognize and fold or remove unfolded proteins (43) . They are also important for proper assembly and/or disassembly of the viral replication complex (44) . They require the adapter protein STIP1 for optimal activity. In the case of SARS-CoV-2, HSP71, HSP71L, and STIP1 were found to interact with the 59 UTR. Dead box RNA helicases such as DDX1 and DHX15 are known to associate with the TRS in MHV (7) . DDX24 was identified as interacting with the 39 UTR of SARS-CoV-2. DDX24 is known to associate with RNA and negatively regulate RIG-I-like receptor signaling, resulting in inhibition of the host antiviral response (45) . Several proteins encoded by SARS-CoV-2, such as nucleocapsid, ORF6, and ORF8, are known to inhibit the host antiviral response (46) . Interaction of DDX24 with the SARS-CoV-2 39 UTR might be an additional strategy to inhibit the host antiviral response. Further studies are required to confirm the above hypothesis.

ATP-binding cassette subfamily E member 1 (ABCE1) is another important host protein that interacts with the 59 UTR. ABCE1 (RNase L inhibitor) inhibits the activity of RNase L, which is activated by the host antiviral response mechanism in response to RNA virus infection or alpha/beta interferon (IFN-a/b) stimulation (47) . Active RNase L cleaves the viral RNA, which is prevented in the presence of ABCE1. It will be interesting to explore the significance of the 59-UTR interaction with ABCE1. Note that ABCE1 was also identified as a direct interaction partner of SARS-CoV-2 RNA by both Schmidt et al. and Flynn et al. (23, 24) . FKBP4 was also found to interact with the 59 UTR. It is a member of the immunophilin protein family and binds to immunosuppressants FK506 and rapamycin (48) . Furthermore, Ras GTPase activating protein binding protein 2 (G3BP2), which is key to stress granule formation, was found to interact with the 59 UTR of SARS-CoV-2. SARS-CoV-2 RNA binding by G3BP2 has also been shown by Flynn et al., and knockout of G3BP2 using CRISPR technology revealed a proviral role of this protein in SARS-CoV-2-infected cells (24) . G3BP1/2 has also been shown to bind to the N protein of SARS-CoV-2 (36) . Stress granules play key roles in controlling viral infections (49) . The N protein of SARS-CoV-2 is predicted to associate with the 59 UTR. The functional significance of the interaction of both N and 59 UTR with G3BP2 during the course of SARS-CoV-2 remains to be explored. The 59 UTR was also found to interact with the exosome endoribonuclease RRP4, which is involved in cellular RNA processing and degradation. The RNA exosome complex is a quality control mechanism of the host that regulates mRNA turnover and degrades aberrant RNAs. SARS-CoV-2 might modulate this pathway for its own benefit.

The 59 UTR was also found to interact with Lamp2a, which is another key protein involved in quality control processes of the host. Lamp2a is the cellular receptor for chaperone-mediated autophagy (CMA) (50) . Activation of CMA leads to localization of Lamp2a in the lysosome, as it recognizes and carries the cargo to the lysosome for degradation. Although there was an increase in the Lamp2 level in SARS-CoV-2infected Vero E6 and Huh7 cells, we did not detect CMA activation in the infected cells, which suggests that increased Lamp2a may be sequestered away from binding to the CMA cargo due to its interaction with the viral 59 UTR. Our data show an increase in autophagic flux (macroautophagy) in SARS-CoV-2-infected cells and a significant reduction in viral RNA level by inhibition of autophagy. Therefore, it appears that increased autophagic flux promotes SARS-CoV-2 replication, as seen in many other RNA viruses (51) . However, there was no change in autophagolysosome formation in SARS-CoV-2-infected cells. A similar phenomenon has been observed in the case of HCV infection (52) . A lack of Lamp2 protein increased the level of viral RNA and protein in SARS-CoV-2-infected cells. Therefore, Lamp2a interaction with the 59 UTR is unlikely to play a role in promoting viral replication.

Lamp2b and Lamp2c isoforms are known to directly interact with RNA and DNA, leading to RNautophagy/DNautophagy (53) . Lamp2c is predominantly involved in importing nucleic acids to the lysosome for degradation (54) . In order to test the role of different Lamp2 isoforms during SARS-CoV-2 infection, Lamp2a and Lamp2b isoform-specific siRNAs were used.

No siRNA could be designed against the Lamp2c isoform. However, pan-Lamp2 siRNA used in our study targets all three isoforms, as it recognizes the 59 end of the Lamp2 transcript (see details in Materials and Methods). Note that Lamp2 isoforms differ in their Cterminal regions. Silencing of Lamp2a significantly reduced the level of total Lamp2 in Huh7 cells and increased the level of viral RNA, whereas its overexpression decreased the level of viral RNA in SARS-CoV-2-infected cells, suggesting its antiviral property. Silencing of Lamp2b moderately decreased the level of total Lamp2, but the level of viral RNA remained unaltered in SARS-CoV-2-infected cells. However, overexpression of Lamp2b reduced the level of viral RNA in infected cells. These differences might be attributed to the fact that Lamp2a, being the predominant isoform, maintains antiviral activity in the absence of Lamp2b; however, overexpression of Lamp2b might be affecting viral infection directly/indirectly by inducing RNautophagy/DNautophagy. Therefore, Lamp2b may not have a role in SARS-CoV-2 infection at its endogenous level. Although Lamp2c is expressed at a low level in Huh7 cells, its role in SARS-CoV-2 infection could not be confirmed. The Lamp2a-59-UTR interaction may be involved in delivering viral RNA to the endosome, for recognition by TLR7, the sensor for single-stranded RNA (ssRNA). The Lamp2a-59-UTR interaction may also be involved in sequestering Lamp2a away from inducing chaperone-mediated autophagy. At the same time, increased autophagic flux provides energy and prevents apoptosis of infected cells, which provides a favorable environment for the virus to complete its life cycle. Further studies are required to understand the actual process. Nevertheless, the current study identifies the repertoire of host proteins that associate with SARS-CoV-2 59 and 39 UTRs and characterizes the role of host Lamp2a protein during SARS-CoV-2 infection. . siRNAs against human Lamp2a and Lamp2b isoforms were designed using the GenScript siRNA target finder tool and synthesized at Eurogentec (Liege, Belgium). The following sequences were selected: Lamp2a, 59GGCAGGAGUACUUAUUCUAGU39; Lamp2b, 59GUGUUCGCUGGAUGAUGAC39. A literature search revealed that similar sequences have been used earlier to specifically silence Lamp2a and Lamp2b isoforms in human cell lines (55, 56) . However, the same siRNA sequence did not match Lamp2a and Lamp2b isoforms of Chlorocebus aethiops, and they were not effective in silencing the corresponding isoforms expressed in Vero E6 cells. Pan-Lamp2 siRNA was effective in both Huh7 and Vero E6 cells, as it targeted the 59 end of the RNA, which is conserved across isoforms in both species. The following are the sequences of siRNAs present in the SMARTpool pan-Lamp2 siRNA: 59CUCAAUAGCACCAUUA39, 59GCAUGUAUUUGGUUAAUGG39, 59GCAUUGGAACUUAAUUUGA39, and 59AAAUGCCACUUGCCUUUAU39.

Mammalian cell culture, transfection, and cell viability assay. Vero E6 and HEK 293T cells were obtained from the ATCC (VA, USA). Huh7 cells have been described previously (57) . Cells were maintained in Dulbecco's modified Eagle medium (DMEM) containing 10% fetal bovine serum (FBS) and 50 IU/ml penicillin and streptomycin in 5% CO 2 . For plasmid transfection, cells were seeded at 70 to 80% confluence in DMEM plus 10% FBS and incubated overnight. The next day, the cells were transfected with the desired plasmid DNA using Lipofectamine 2000 transfection reagent (Life Technologies, CA, USA) at a 1:1 ratio, in accordance with the manufacturer's instruction. At 6 to 8 h posttransfection, culture medium was replaced with fresh DMEM plus 10% FBS.

For experiments involving siRNA-mediated gene silencing, Huh7 or Vero E6 cells were seeded at 70 to 80% confluence on 12-well tissue culture (TC) dishes and incubated overnight at 37°C, 5% CO 2 . The next day, 25 nmol siRNA was transfected into each well using 0.35 ml DharmaFECT transfection reagent, in accordance with the manufacturer's instructions (Dharmacon, CO, USA). At 18 h posttransfection, culture medium was replaced with DMEM plus 10% FBS and the cells were maintained at 37°C, 5% CO 2 , until further manipulation.

Cell viability was measured using a commercially available kit (CellTiter 96 AQ ueous One Solution cell proliferation assay; Promega, Madison, USA) that employs a tetrazolium salt-based colorimetric assay. Details are as described previously (57) .

RaPID assay. 59 UTRs and 39 UTRs were PCR amplified from the pUC57 vector and cloned into RNA motif plasmid cloning backbone vector (pRMB) at the BsmBI restriction site using the following primers: 59 UTR FP, ATTAAAGGTTTATACCTTCCCAGG; 59 UTR RP, GTTTTCTCGTTGAAACCAGGG; 39 UTR FP, AATCTTTAATCAGTGTGTAACA; 39 UTR RP, TTTTTTTTGTCATTCTCCTAAG. Positive clones were checked by restriction mapping and confirmed by DNA sequencing.

Production of 59-UTR and 39-UTR RNA from the pRMB constructs was verified by transfection of pRMB 59-UTR and pRMB 39-UTR plasmids along with pRMB vector into HEK293T cells, followed by RT-PCR detection of the 59-UTR and 39-UTR RNA using the above-mentioned primer pairs. Expression of BirA ligase in HEK293T cells upon transfection of BASU plasmid was verified by Western blotting (Fig. 1D) . Time durations for biotin treatment were optimized by cotransfection of RNA motif plasmid EDEN15 (pRMB EDEN15) and BASU plasmid at a 6:1 ratio using Lipofectamine 2000 (1:1 ratio) into HEK293T cells. At 42 h posttransfection, 200 mM biotin was added to the medium and cells were incubated for 6, 12, and 18 h. At each time point, whole-cell extract was prepared in 2Â Laemmli buffer and equal amounts of protein were resolved by 10% SDS-PAGE, followed by Western blotting using anti-biotin antibody (Fig. 1E) .

For verifying the interaction between EDEN15 and CUGBP1 by the RaPID assay, HEK293T cells were transfected with pRMB EDEN15 and BASU plasmids ( For mass spectrometry, clarified cell lysate was precipitated in acetone at 220°C for 10 min, followed by storage at 280°C for 20 min. The precipitates were solubilized in 8 M urea. The protein concentration was estimated by using the BCA protein assay kit (Thermo Fisher Scientific, MA, USA).

(i) In-solution digestion and peptide separation. An equal amount of protein (10 mg) from each sample was treated with 10 mM dithiothreitol (DTT; 56°C, 30 min) and alkylated with 20 mM iodoacetamide (IAA) (at room temperature, for 60 min, in the dark). Trypsin (catalog no. T1426; Thermo Fisher Scientific, MA, USA) was added to the samples at a 1:20 (wt/wt) ratio and incubated at pH 8, 37°C, for 24 h. Next, 1% formic acid was added to the samples, and peptides were desalted using a Sep-Pak C 18 cartridge (catalog no. WAT020515; Waters, MA, USA) and subsequently lyophilized in a SpeedVac.

High-capacity streptavidin agarose resins (catalog no. 20361; Thermo Fisher Scientific, MA, USA) were used to pull down the biotinylated peptides. The beads were washed in binding buffer (50 mM Na 2 HPO 4 , 150 mM NaCl, pH 7.2) before use.

Lyophilized peptides were solubilized in 1 ml PBS and incubated with 150 ml washed streptavidin agarose beads for 2 h at room temperature. The beads were washed once in 1 ml PBS, once in 1 ml washing buffer (5% acetonitrile in PBS), and finally once in ultrapure water. Excess liquid was completely removed from the beads, and biotinylated peptides were eluted by adding 0.3 ml of a solution containing 0.1% formic acid and 80% acetonitrile in water by boiling at 95°C for 5 min. A total of 10 elutions were collected and dried together in a SpeedVac. Enriched peptides were desalted with C 18 tips (Thermo Fisher Scientific, MA, USA), and reconstituted with solvent A (2% [vol/vol] acetonitrile, 0.1% [vol/vol] formic acid in water) for LC-MS/MS analysis.

(ii) LC-MS/MS acquisition. LC-MS/MS experiments were performed using a Sciex 5600 1 triple-timeof-flight (TOF) mass spectrometer coupled with a ChromXP reversed-phase 3-mm C 18 -CL trap column (350 mm by 0.5 mm, 120 Å; Eksigent; AB Sciex, MA, USA) and a nanoViper C 18 separation column (75 mm by 250 mm, 3 mm, 100 Å; Acclaim PepMap; Thermo Fisher Scientific, MA, USA) in an Eksigent nanoLC (ultra 2D plus) system. The binary mobile solvent system used was as follows: solvent C, 2% (vol/ vol) acetonitrile, 0.1% (vol/vol) formic acid in water; solvent B, 98% (vol/vol) acetonitrile, 0.1% (vol/vol) formic acid. The peptides were separated at a flow rate of 200 nl/min in a 60-min gradient with a total run time of 90 min. The MS data of each condition were acquired in IDA (information-dependent acquisition) with high sensitivity mode. Each cycle consisted of 250-and 100-ms acquisition times for MS1 (m/z 350 to 1,250 Da) and MS/MS (100 to 1,800 m/z) scans, respectively, with a total cycle time of ;2.3 s. Each condition was run in triplicate.

(iii) Protein identification and quantification. All raw files (.wiff) were searched using ProteinPilot software (version 4.5; Sciex) with the Mascot algorithm for protein identification and semiquantitation against the Swiss-Prot_57.15 database (20,266 sequences after application of Homo sapiens taxonomy filter). The search parameters for identification of biotinylated peptides were as follows: (i) trypsin as a proteolytic enzyme (with up to two missed cleavages); (ii) peptide mass error tolerance of 20 ppm; (iii) fragment mass error tolerance of 0.20 Da; and (iv) carbamido-methylation of cysteine (157.02146 Da), oxidation of methionine (115.99492 Da), deamination of NQ (10.98416), and biotinylation of lysine (1226.07759 Da) as variable modifications. The quality of data between different samples and replicates was monitored by a Pearson correlation plot of peptide intensity against each run.

(iv) Data analysis. Proteins with at least one corrected biotinylated peptide and a posterior error probability (PEP) score of $15 were considered to be identified successfully and extracted from the Gaussian smoothing curve (note that PEP score refers to the probability that the observed peptide spectrum matches are incorrect). Next, all data were analyzed using a Web-based tool, Bioinformatics & Evolutionary Genomics (http://bioinformatics.psb.ugent.be/webtools/Venn/) to generate the Venn diagram to identify proteins that are unique interaction partners of 59-UTR and 39-UTR RNA. The background-subtracted data set was sorted on the basis of the parameters of a minimum of 2 unique peptides and a "prot score" of 40 or more to generate the final list of proteins, which were considered for further studies ( Table 1 ). Note that "prot score" refers to the overall protein score calculated by Mascot, taking into account all observed mass spectra which matches amino acid sequences within a particular protein. The confidence level of the protein match was ensured by setting a high "prot score" threshold.

Bioinformatics analysis. RNA secondary structure was analyzed using the mfold program (http:// www.unafold.org/mfold/applications/rna-folding-form.php), based on a minimum free energy calculation at 25°C (58) . The virus-host RPPI data set was visualized using Cytoscape (version 3.1.0) (27) . NetworkAnalyzer plug-in in Cytoscape was used to compute the topological parameters and centrality measures of the network. The CyTarget Linker plug-in in Cytoscape and the Drug Gene Interaction Database (DGID) were used to search for drug targets (30, 31) . Gene ontology (GO) and Reactome pathway analysis was performed using the Gene Set Enrichment Analysis tool (https://www.gsea-msigdb .org/gsea/index.jsp) (28, 29) .

SARS-CoV-2 infection. SARS-CoV-2 was obtained from BEI Resources (NR-52281; SARS-related coronavirus 2 isolate ISA-WA1/2020), amplified in Vero E6 cells in the biosafety level 3 (BSL3) facility of THSTI, India, titrated, and stored frozen in aliquots. For SARS-CoV-2 infection studies, 200 ml of stock virus was diluted in serum-free medium to 2,000 50% tissue culture infective doses (TCID 50 )/ml and added to a Vero E6/Huh7 cell monolayer (seeded in a 24-well plate) for 1 h at 37°C, supplemented with 5% CO 2 . At 1 h postincubation, the infection medium was removed, cells were washed twice with 500 ml of serum-free medium, and fresh DMEM plus 10% FBS was added. In the case of plasmid overexpression or siRNA transfection study, cells were transfected with the respective DNA or siRNA 24 h prior to infection with SARS-CoV-2. In the case of 3-MA treatment, 5 mM (final concentration) 3-MA was added to the culture medium during infection, again added to the complete medium after removal of the infection medium, and maintained for 48 h, followed by collection of culture medium and cells and subsequent experiments.

Preparation of RNA probe for fluorescence in situ hybridization (FISH). Sequence corresponding to the 59 300 bases of SARS-CoV-2 was PCR amplified from pUC57 vector and cloned into the pJet1.2 vector (Thermo Fisher Scientific, MA, USA) under the control of the T7 promoter. pJet1.2_59-300 plasmid was linearized by restriction digestion with XbaI. DIG-11-UTP (catalog no. 11209256910; Roche, Basel, Switzerland)-labeled RNA was in vitro synthesized using a MAXIscript in vitro transcription kit (Thermo Fisher Scientific, MA, USA), in accordance with the manufacturer's instructions. Template DNA was removed by treatment with DNase I, followed by precipitation of RNA using LiCl. An aliquot of the probe was resolved by agarose gel electrophoresis to monitor its size and integrity.

FISH. Fluorescence in situ hybridization (FISH) was done as described previously, with minor modifications in which a Tyramide SuperBoost kit (catalog no. B40933; Thermo Fisher Scientific, MA, USA) was used to detect the fluorescence signal (59) . In summary, Vero E6 cells were seeded at 70 to 80% confluence on a coverslip overnight. The next day, cells were infected with the SARS-CoV-2 (see "SARS-CoV-2 infection") and incubated for 24 or 48 h. Cells were then washed three times in PBS, followed by fixation in 4% paraformaldehyde for 10 min at room temperature. Cells were rehydrated in 2Â SSC buffer (300 mM NaCl, 30 mM sodium citrate) for 10 min at room temperature, followed by incubation with 50% formamide in 2Â SSC buffer for 30 min at room temperature. Coverslips were then washed four times with warm hybridization buffer (10% formamide in 2Â SSC, warmed to 70°C), followed by incubation with hybridization buffer containing 2 ng/ml of probe for 3 days at 42°C in a humified incubator. Cells were washed two times with 4Â SSC buffer for 10 min each, at 42°C, and incubated with 20 mg/ml RNase A in 2Â SSC buffer for 30 min at 37°C. Cells were then washed once with 2Â SSC buffer and once with 0.1Â SSC buffer for 10 min at 42°C. Endogenous peroxidase activity was quenched by adding 50 ml 3% H 2 O 2 solution (provided in the Tyramide SuperBoost kit) and incubating at room temperature for 1 h. Cells were then blocked in 4% bovine serum albumin (BSA) (in PBS) for 1 h at room temperature, followed by incubation with anti-LAMP2 (1:50 dilution) and biotin-conjugated anti-DIG antibody (1:200 dilution) prepared in 4% BSA in PBST (PBS plus 0.2% Tween 20) overnight at 4°C. The next day, the cells were washed three times in PBS (10 min each) and incubated with HRP-conjugated streptavidin (provided in the Tyramide SuperBoost kit) for 60 min at room temperature Next, the cells were washed three times in PBS and incubated with goat-anti rabbit IgG-Alexa Fluor 488 (1:1,000 dilution, prepared in 4% BSA plus PBS plus 0.1% Tween 20) for 1 h at room temperature. Cells were washed three times in PBS. Next, freshly prepared tyramide working solution was added to the cells and incubated for 5 min at room temperature, followed by the addition of stop solution (provided with the Tyramide SuperBoost kit) and incubation for 3 min. Next, cells were washed three times in PBS and coverslips were mounted on a slide using antifade gold. Images were acquired using a 100Â objective in a confocal microscope (Olympus FV3000) and analyzed by Image lab Fiji software.

RNA isolation and RT-qPCR assay. Intracellular RNA was isolated using TRI reagent (MRC, MA, USA), followed by reverse transcription (RT) using a FIREScript cDNA synthesis kit (Solis Biodyne, Estonia). RNA from culture medium was isolated using a Qiagen viral RNA minikit (Qiagen, Germany), followed by RT using a FIREScript cDNA synthesis kit (Solis Biodyne, Estonia). Random hexamers were used in cDNA synthesis. SYBR green-based quantitative real-time PCR (RT-qPCR) was done as described earlier (57) . The following primers were used: SCoV2 QPCR FP, 59-TGGACCCCAAAATCAGCGAA; SCoV2 QPCR RP, 59-TCGTCTGGTAGCTCTTCGGT; RP II FP, 59-GCACCACGTCCAATGACAT; RP II RP, 59-GTCGGCTGCTTCCATAA;  RP FP, 59-AGATTTGGACCTGCGAGCG; RP RP, 59-GAGCGGCTGTCTCCACAAGT; LAMP2A FP, 59-TATGTGCAA  CAAAGAGCAGAC3; LAMP2A RP, 59-AAGCCAGCAACACTAGAATAAG3; LAMP2B FP: 59-TATGTGCAACAAA  GAGCAGAC3, LAMP2B RP, 59-TGCCAATTACGTAAGCAATCA. TaqMan-based RT-qPCR was done as described earlier, by following the protocol suggested by the CDC, USA (60). The following primers and probes were used: N1 FP, 59-GACCCCAAAATCAGCGAAAT; N1 RP, 59-TCTGGTTACTGCCAGTTGAATCTG; N1 probe, 59-FAM-ACCCCGCATTACGTTTGGTGGACC-BHQ1; N2 FP, 59-TTACAAACATTGGCCGCAAA; N2 RP, 59-GCGCGACATTCC GAAGAA; N2 probe, 59-FAM-ACAATTTGCCCCCAGCGCTTCAG-BHQ1; RP FP, 59-AGATTTGGACCTGCGAGCG; RP RP, 59-GAGCGGCTGTCTCCACAAGT; RP probe, 59-FAM-TTCTGACCTGAAGGCTCTGCGCG-BHQ1. Absolute quantification was used in SYBR green RT-qPCRs. A standard plot was generated by serial dilution of a known quantity of template. SARS-CoV-2 PCR values were normalized to that of RNA polymerase II (RP II, intracellular RNA) or RNase P (RP, culture medium RNA).

Statistics. Data are represented as the mean 6 standard error of the mean (SEM) of three experiments. P values were calculated using a two-tailed Student t test (paired two samples for means).

Immunofluorescence assay (IFA). Confocal imaging was performed as described previously (57) . In brief, Huh7 and Vero E6 cells were fixed with 4% paraformaldehyde for 10 min at room temperature, followed by incubation in blocking buffer (4% BSA in PBS) for 1 h at room temperature and incubation with Lamp2 and LC3b antibodies (1:50 and 1:50 dilutions, respectively) or anti-N antibody (1:50 dilution) in antibody dilution buffer (3% BSA in PBS plus 0.1% Tween 20) for 16 h, at 4°C. Coverslips were washed three times in PBS, followed by incubation with a 1:500 dilution of goat anti-rabbit-Alexa Fluor 488 and a 1:500 dilution of goat anti-mouse-Alexa Fluor 647 antibodies (Thermo Fisher Scientific, MA, USA) or goat anti-rabbit-Alexa Fluor 594 antibody (for anti-N detection; Thermo Fisher Scientific, MA, USA) in antibody dilution buffer at room temperature for 1 h. Coverslips were washed three times in PBS and mounted on glass slides using antifade gold reagent (Thermo Fisher Scientific, MA, USA). Images were acquired using a 60Â objective in a confocal microscope (Olympus FV3000) and analyzed by Image lab Fiji software.

Western blot assay. Samples were resolved by SDS-PAGE, transferred to a 0.4-mm polyvinylidene difluoride (PVDF) membrane. Membranes were blocked for 1 h at room temperature using 5% skimmed milk (in PBS). Next, membranes were incubated overnight with primary antibody in PBST (PBS plus 0.05% Tween 20) plus 5% skimmed milk at 4°C. Blots were washed 3 times in PBST, followed by incubation with HRPtagged secondary antibody at room temperature for 1 h. Blots were washed 3 times in PBST, and protein bands were visualized by enhanced chemiluminescence using a commercially available kit (Bio Rad, CA, USA).

Data availability. The mass spectrometry proteomics data are available in the MassIVE repository, which is a part of ProteomeXchange, under identifier number PXD026754. The data can be accessed directly at http://proteomecentral.proteomexchange.org/cgi/GetDataset?ID=PXD026754.

Supplemental material is available online only. 

Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission

Severe acute respiratory syndrome coronavirus 2: from gene structure to pathogenic mechanisms and potential therapy

Characteristics of SARS-CoV-2 and COVID-19

Potential causes and consequences of gastrointestinal disorders during a SARS-CoV-2 infection

Novel human coronavirus (SARS-CoV-2): a lesson from animal coronaviruses

Coronaviruses: an updated overview of their replication and pathogenesis

RNA-RNA and RNA-protein interactions in coronavirus replication and transcription

The structure and functions of coronavirus genomic 39 and 59 ends

RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses: a first look

Secondary structure of the SARS-CoV-2 59-UTR

Continuous and discontinuous RNA synthesis in coronaviruses

A U-turn motif-containing stem-loop in the coronavirus 59 untranslated region plays a functional role in replication

A hypervariable region within the 39 cis-acting element of the murine coronavirus genome is nonessential for RNA synthesis but affects pathogenesis

Heterogeneous nuclear ribonucleoprotein A1 binds to the transcription-regulatory region of mouse hepatitis virus RNA

Polypyrimidine tract-binding protein binds to the leader RNA of mouse hepatitis virus and serves as a regulator of viral transcription

Polypyrimidine-tract-binding protein affects transcription but not translation of mouse hepatitis virus RNA

Human coronavirus: host-pathogen interaction

Heterogeneous nuclear ribonucleoprotein a1 binds to the 39-untranslated region and mediates potential 59-39-end cross talks of mouse hepatitis virus RNA

Mitochondrial HSP70, HSP40, and HSP60 bind to the 39 untranslated region of the murine hepatitis virus genome

RNA-protein interaction detection in living cells

Posterior error probabilities and false discovery rates: two sides of the same coin

Molecular biology and replication of hepatitis E virus

The SARS-CoV-2 RNA-protein interactome in infected human cells

Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions

Identification of required host factors for SARS-CoV-2 infection in human cells

Genomewide CRISPR screens reveal host factors critical for SARS-CoV-2 infection

Integration of biological networks and gene expression data using Cytoscape

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

DrugBank 4.0: shedding new light on drug metabolism

Integration of the drug-gene interaction database (DGIdb 4.0) with open crowdsource efforts

Potent inhibition of tubulin polymerisation and proliferation of paclitaxel-resistant 1A9PTX22 human ovarian cancer cells by albendazole

Molecular characterization of a novel intracellular hyaluronan-binding protein

Additive blockade of beta 2-integrin adhesion of eosinophils by salmeterol and fluticasone propionate

DrugBank: a comprehensive resource for in silico drug discovery and exploration

Canonical and noncanonical autophagy as potential targets for COVID-19

In vitro and animal models for SARS-CoV-2 research

The family of LAMP-2 proteins arises by alternative splicing from a single gene: characterization of the avian LAMP-2 gene and identification of mammalian homologs of LAMP-2b and LAMP-2c

Danon disease: a phenotypic expression of LAMP-2 deficiency

Mitochondrial autophagy promotes cellular injury in nephropathic cystinosis

Evidence that the genomic RNA of hepatitis E virus is capped

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

Heat-shock protein regulation of protein folding, protein degradation, protein function, and apoptosis

Differential roles of Hsp70 and Hsp90 in the assembly of the replicase complex of a positive-strand RNA plant virus

DDX24 negatively regulates cytosolic RNA-mediated innate immune signaling

The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway

The biological regulation of ABCE1

Conformational entropy of FK506 binding to FKBP12 determined by nuclear magnetic resonance relaxation and molecular dynamics simulations

Regulation of stress granules in virus systems

Unique properties of lamp2a compared to other lamp2 isoforms

Enteroviral infection inhibits autophagic flux via disruption of the SNARE complex to enhance viral replication

Hepatitis C virus infection increases autophagosome stability by suppressing lysosomal fusion through an Arl8b-dependent mechanism

RNautophagy/DNautophagy possesses selectivity for RNA/DNA substrates

Discovery of a novel type of autophagy targeting RNA

Establishment of a novel fluorescence-based method to evaluate chaperone-mediated autophagy in a single neuron

Resveratrol-induced apoptosis depends on the lipid kinase activity of Vps34 and on the formation of autophagolysosomes

Endoplasmic reticulum stress induced synthesis of a novel viral factor mediates efficient replication of genotype-1 hepatitis E virus

Mfold web server for nucleic acid folding and hybridization prediction

The technique of in situ hybridization

Gargle lavage as a viable alternative to swab for detection of SARS-CoV-2

The RNA motif plasmid cloning backbone (pRMB), BASU RaPID plasmid, and RNA motif plasmid EDEN15 were kindly gifted by Paul Khavari. pCDNA Lamp2b was a gift from Joshua Leonard, and pCDNA Lamp2c was a gift from Janice Blum. SARS-related coronavirus 2, isolate USA-WA1/2020 (NR-52281), was deposited by the Centers for Disease Control and Prevention and obtained through BEI Resources, NIAID, NIH, USA. We thank Tripti Shrivastava for generously providing the rabbit polyclonal anti-N antibody (Genetex, Inc., USA).This study was funded by the Science and Engineering Research Board (SERB), Government of India, by an IRHPA grant (IPA/2020/000233) to M.S. and a THSTI core grant to M.S. R.V. and S.S. are supported by a senior research fellowship from the Council of Scientific and Industrial Research, Government of India, and S.K. is supported Verma et al.